Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycaemic Response to Sulphonylureas in Type 2 Diabetes
NCT00738088Phase 4Terminated
- Sponsor
- NHS Tayside
- Start
- Jun 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gliclazide in type 2 diabetes mellitus (T2DM), sponsored by NHS Tayside. Started Jun 2007; status: terminated.
02
Drugs
gliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00738088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738088.